openPR Logo
Press release

Emerging Growth Patterns Driving Expansion in the Contraceptives Market

12-17-2025 09:30 AM CET | Health & Medicine

Press release from: The Business Research Company

Contraceptives Market

Contraceptives Market

The contraceptives market is positioned for significant expansion in the coming years, driven by several evolving factors and innovations. As awareness and accessibility grow worldwide, the sector is adapting to meet diverse needs through advanced technologies and broader availability. Below is a detailed exploration of the market size, key players, trends, and segment dynamics shaping the contraceptives industry.

Projected Growth and Market Size of the Contraceptives Industry
The contraceptives market is expected to experience robust growth, reaching $40 billion by 2029 with a compound annual growth rate (CAGR) of 7.7%. This upward trajectory is fueled by increasing attention on male contraceptive options, improved access to contraception in developing regions, and the incorporation of digital health technologies into contraceptive care. Rising demand for long-acting reversible contraceptives (LARCs) and the greater availability of over-the-counter options through online platforms also contribute to this growth. Key trends influencing the market include advancements in contraceptive technology, a shift toward non-hormonal and natural methods, expanded over-the-counter availability, focus on discreet and user-friendly products, and the growing role of telemedicine in counseling and prescription services.

Download a free sample of the contraceptives market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Important Drivers Behind the Contraceptives Market Expansion
A growing focus on male contraception is one of the critical factors propelling the market forward. This expanding interest helps diversify contraceptive options beyond traditional female-centric methods, encouraging wider acceptance and use among men.
Additionally, increasing access to contraceptive products in developing countries plays a vital role. Enhanced healthcare infrastructure and awareness campaigns are enabling more individuals to obtain contraceptives, particularly in regions where usage had previously been limited.

Leading Companies Dominating the Contraceptives Market
The contraceptives market includes several prominent players such as Merck & Co. Inc., Bayer AG, Church & Dwight* Co. Inc., Cipla Inc., and Reckitt Benckiser Group plc. Others active in the space are Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., and Glenmark Pharmaceuticals Limited. Additional key names include HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., and Chongqing Pharmaceutical Group Co. Ltd.

View the full contraceptives market report:
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Recent Market Moves Highlighted by Insud Pharma's Acquisition
In March 2024, Spain-based Insud Pharma, a pharmaceutical manufacturer, acquired the oral and injectable contraceptives portfolio from Viatris, a US pharmaceutical company, for an undisclosed sum. This purchase allows Insud Pharma to broaden its women's health product offerings, strengthening its position in reproductive healthcare. By integrating Viatris' contraceptive products, Insud Pharma aims to meet increasing demand with a wider range of contraceptive solutions.

Emerging Innovations and Opportunities in the Contraceptives Sector
Industry leaders are focusing on developing new contraceptive technologies such as Single Rod Subdermal Implants and Subcutaneous Injectable Contraceptives. These novel methods emphasize convenience, improved efficacy, and long-term birth control, reducing the need for frequent dosing.
For example, in October 2023, India's Health and Family Welfare Ministry introduced these two new contraceptive options under the National Family Planning Programme to enhance family planning services. The initiative supports improved maternal and infant health by offering safer and more effective contraceptive choices. This reflects a broader effort to upgrade reproductive health services, particularly in Karnataka, ensuring women have access to advanced and reliable contraceptive methods.

Market Segmentation and the Largest Contraceptive Product Share
The contraceptives market is segmented across several categories:
1) Product Types: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, and Intra-Uterine Devices (IUDs)
2) Age Groups: 15-24 Years, 25-34 Years, 35-44 Years, and 44 Years and above
3) Distribution Channels: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, and Other Channels

Further subcategories include:
- Oral Contraceptive Pills divided into Combination Pills and Progestin-Only Pills
- Topical Contraceptives including Transdermal Patches and Gel Applications
- Injectables split into Hormonal and Non-Hormonal Injectables
- Diaphragms consisting of Silicone and Latex variants
- Vaginal Rings divided into Hormonal and Non-Hormonal types
- Condoms categorized as Male and Female Condoms
- Contraceptive Sponges split into Non-Hormonal and Hormonal options
- Subdermal Implants including Hormonal and Non-Hormonal forms
- IUDs divided into Hormonal and Copper types

This detailed segmentation highlights the diverse range of contraceptive products designed to meet the varied needs of users across different demographics and preferences.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerging Growth Patterns Driving Expansion in the Contraceptives Market here

News-ID: 4318619 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the